Literature DB >> 16992149

Observations on intrinsic kinin-forming factors in human plasma: the effect of acid, acetone, chloroform, heat and euglobulin separation on kinin formation.

V Eisen.   

Abstract

Entities:  

Year:  1963        PMID： 16992149      PMCID： PMC1359349          DOI： 10.1113/jphysiol.1963.sp007119

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  26 in total

1.  Pain-producing substance in human inflammatory exudates and plasma.

Authors:  D ARMSTRONG; J B JEPSON; C A KEELE; J W STEWART
Journal:  J Physiol       Date:  1957-02-15       Impact factor: 5.182

2.  Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. VI. Isolation and properties of permeability factor and its inhibitor in human plasma.

Authors:  P J MILL; J M ELDER; A A MILES; D L WILHELM
Journal:  Br J Exp Pathol       Date:  1958-08

3.  The esterase activity of the fibrinolytic system.

Authors:  M LASSEN
Journal:  Biochem J       Date:  1958-07       Impact factor: 3.857

4.  Formation of plasma kinins by plasmin.

Authors:  G P LEWIS
Journal:  J Physiol       Date:  1958-02-17       Impact factor: 5.182

5.  Methods for the evaluation of human fibrinolysis; studies with two combined technics.

Authors:  K N VON KAULLA; R L SCHULTZ
Journal:  Am J Clin Pathol       Date:  1958-02       Impact factor: 2.493

6.  Role of Hageman factor in the initiation of clotting by glass; evidence that glass frees Hageman factor from inhibition.

Authors:  O D RATNOFF; J M ROSENBLUM
Journal:  Am J Med       Date:  1958-08       Impact factor: 4.965

7.  Formation and properties of the activator of plasminogen and of human and bovine plasmin.

Authors:  S MULLERTZ
Journal:  Biochem J       Date:  1955-11       Impact factor: 3.857

8.  [Chemical and pharmacologic differentiation of kallikreins of various origins].

Authors:  E WERLE; L MAIER
Journal:  Biochem Z       Date:  1952

9.  Observations on chemical excitants of cutaneous pain in man.

Authors:  D ARMSTRONG; R M L DRY; C A KEELE; J W MARKHAM
Journal:  J Physiol       Date:  1953-05-28       Impact factor: 5.182

10.  Studies of the plasmin system. II. Inhibition of plasmin by serum or plasma.

Authors:  P S NORMAN
Journal:  J Exp Med       Date:  1958-07-01       Impact factor: 14.307
View more
  18 in total

Review 1.  THE FIBRINOLYTIC MECHANISM IN HAEMOSTASIS: A REVIEW.

Authors:  J L STAFFORD
Journal:  J Clin Pathol       Date:  1964-09       Impact factor: 3.411

2.  Kinin formation and fibrinolysis in human plasma.

Authors:  V Eisen
Journal:  J Physiol       Date:  1963-05       Impact factor: 5.182

3.  Permeability factor and kininogenase in guinea-pig serum fractions.

Authors:  B Mason
Journal:  Br J Exp Pathol       Date:  1972-08

4.  On the endogenous mechanism of kinin release. I. Attempts at discriminating kallikreins.

Authors:  R Jahrreiss; E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

5.  The profile of vascular permeability factors in dilute guinea-pig plasma.

Authors:  B Mason
Journal:  Br J Exp Pathol       Date:  1972-12

6.  Separation of kinin-forming factors in human plasma.

Authors:  V Eisen; K L Glanville
Journal:  Br J Exp Pathol       Date:  1969-10

7.  Effects of suramin on complement, blood clotting, fibrinolysis and kinin formation.

Authors:  V Eisen; C Loveday
Journal:  Br J Pharmacol       Date:  1973-12       Impact factor: 8.739

8.  Effect of thermal injury on the kinin system in rabbit hind limb lymph.

Authors:  G P Lewis; W A Wawretschek
Journal:  Br J Pharmacol       Date:  1971-09       Impact factor: 8.739

9.  Permeability-increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization.

Authors:  V H Donaldson; O D Ratnoff; W Dias Da Silva; F S Rosen
Journal:  J Clin Invest       Date:  1969-04       Impact factor: 14.808

10.  The isolation of human plasma prekallikrein.

Authors:  D J McConnell; B Mason
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.